Approval · Notice of Compliance 21960 · 2019
RAMIPRIL: Notice of Compliance 21960
Issued March 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21960
- Date
- March 12, 2019
- Company
- Altamed PharmaBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- ALTACE (Sanofi-Aventis Canada Inc.)